RISK FACTORS FOR SKELETAL-RELATED EVENTS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER PATIENTS WITH BONE METASTASES

被引：0
|
作者：
Ulas, A. [1 ]
Bilici, A. [2 ]
Tokluoglu, S. T. [3 ]
Akinci, S. [4 ]
Silay, K. [5 ]
Turkoz, F. Paksoy [6 ]
Durnali, A. [3 ]
Oksuzoglu, B. O. [3 ]
Alkis, N. [3 ]
机构：
[1] Ankara Ataturk Res & Teaching Hosp, Dept Med Oncol, Ankara, Turkey
[2] Medipol Mega Hosp Complex Univ Hosp, Med Oncol, Istanbul, Turkey
[3] Dr Abdurrahman Yurtaslan Ankara Onkol Training &, Dept Med Oncol, Ankara, Turkey
[4] Ankara Ataturk Res & Teaching Hosp, Dept Hematol, Ankara, Turkey
[5] Ankara Ataturk Res & Teaching Hosp, Dept Internal Med, Ankara, Turkey
[6] Ataturk Chest Dis & Chest Surg Educ & Res Hosp, Med Oncol, Ankara, Turkey
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
10.1093/annonc/mdv050.41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The risk factors for brain metastases in patients with non-small cell lung cancer
    Lim, Jun Hyeok
    Um, Sang-Won
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [22] Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate—a post hoc analysis of a randomized clinical trial
    Hirotaka Miyashita
    Christina Cruz
    Cardinale Smith
    Supportive Care in Cancer, 2021, 29 : 1629 - 1633
  • [23] Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases
    Tunn, Ulf W.
    Stenzl, Amulf
    Schultze-Seemann, Wolfgang
    Strauss, Arne
    Kindler, Manfred
    Miller, Kurt
    Wirth, Manfred P.
    Zantl, Niko
    Schulze, Matthias
    May, Christoph
    Ruebel, Amelie
    Birkholz, Katrin
    Gruenwald, Viktor
    CANADIAN JOURNAL OF UROLOGY, 2012, 19 (03) : 6261 - 6267
  • [24] Bisphosphonates in prevention and control of skeletal-related events in cancer patients with bone metastases
    Drosik, Kazimierz
    Krzakowski, Maciej
    Jarosz, Jerzy
    Kraj, Maria
    Krzemieniecki, Krzysztof
    Pienkowski, Tadeusz
    Utracka-Hutka, Beata
    Jassem, Jacek
    Szczylik, Cezary
    Wojtukiewicz, Marek
    Ziobro, Marek
    ONCOLOGY IN CLINICAL PRACTICE, 2006, 2 (04): : 152 - 164
  • [25] The cost of treating skeletal-related events in patients with bone metastases secondary to breast, lung, or prostate cancer
    Barber, B.
    Oglesby, A.
    Lage, M. J.
    Harrison, D. J.
    Jun, S.
    VALUE IN HEALTH, 2008, 11 (03) : A69 - A69
  • [26] Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate-a post hoc analysis of a randomized clinical trial
    Miyashita, Hirotaka
    Cruz, Christina
    Smith, Cardinale
    SUPPORTIVE CARE IN CANCER, 2021, 29 (03) : 1629 - 1633
  • [27] Risk factors of bone metastasis and skeletal-related events in high-risk breast cancer patients
    Anwar, S. L.
    Avanti, W. S.
    Cahyono, R.
    Choridah, L.
    Harahap, W. A.
    Aryandono, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S1265 - S1265
  • [28] Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents
    Tanaka, Ryota
    Yonemori, Kan
    Hirakawa, Akihiro
    Kinoshita, Fumie
    Takahashi, Naoki
    Hashimoto, Jun
    Kodaira, Amakoto
    Yamamoto, Harukaze
    Yunokawa, Mayu
    Shimizu, Chikako
    Fujimoto, Manabu
    Fujiwara, Yasuhiro
    Tamura, Kenji
    ONCOLOGIST, 2016, 21 (04): : 508 - 513
  • [29] Exploiting machine learning for predicting skeletal-related events in cancer patients with bone metastases
    Wang, Zhiyu
    Wen, Xiaoting
    Lu, Yaohong
    Yao, Yang
    Zhao, Hui
    ONCOTARGET, 2016, 7 (11) : 12612 - 12622
  • [30] Re: "Prediction of skeletal-related events in patients with non-small cell lung cancer"-use of Spine Instability Neoplastic Score (SINS)
    Arana, Estanislao
    Kovacs, Francisco M.
    Royuela, Ana
    Asenjo, Beatriz
    Perez-Ramirez, Uersula
    Zamora, Javier
    SUPPORTIVE CARE IN CANCER, 2016, 24 (08) : 3273 - 3274
12345